BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29.07.2019

Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Delayed Graft Function in Kidney Transplantation: Developing Drugs for Prevention." The purpose of this guidance is to assist sponsors in the clinical development of drugs for the prevention of delayed graft function (DGF) in kidney transplantation. This guidance finalizes the draft guidance of the same name issued March 23, 2017.

Source: Federal Register — Food and Drug AdministrationOpen original release →